ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q1 2024

Type / Class
Equity / Common Stock, par value $0.001
Symbol
ASMB on Nasdaq
Shares outstanding
15,535,831
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GILEAD SCIENCES, INC. 29% -3% 4,505,391 +104% GILEAD SCIENCES, INC. 08 Aug 2025

Institutional Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$7,065,741 0
2023 Q4 8,647,319 $7,090,909 -$876,714 $0.82 42
2023 Q3 9,538,435 $8,441,336 -$822,997 $0.88 32
2023 Q2 10,465,062 $12,032,628 -$1,413,288 $1.15 31
2023 Q1 12,058,487 $10,132,844 -$2,696,791 $0.84 37
2022 Q4 13,870,477 $18,026,999 -$3,469,917 $1.30 36
2022 Q3 16,595,417 $27,215,067 -$1,040,505 $1.64 47
2022 Q2 17,189,015 $36,094,086 -$3,856,058 $2.10 51
2022 Q1 19,078,839 $39,299,944 -$9,005,495 $2.06 52
2021 Q4 23,096,231 $53,810,453 -$9,786,088 $2.33 57
2021 Q3 22,706,616 $79,015,136 -$15,106,116 $3.48 61
2021 Q2 26,947,044 $104,548,485 -$7,719,587 $3.88 84
2021 Q1 28,282,867 $131,476,551 +$3,545,588 $4.60 102
2020 Q4 24,634,057 $149,037,039 -$151,097,323 $6.05 104
2020 Q3 30,096,975 $494,769,297 +$965,292 $16.44 115
2020 Q2 29,837,651 $696,745,173 +$27,157,586 $23.32 102
2020 Q1 28,382,987 $420,990,715 +$9,168,058 $14.83 95
2019 Q4 28,127,429 $575,488,046 +$162,191,890 $20.46 98
2019 Q3 20,550,190 $202,209,941 -$7,423,771 $9.83 95
2019 Q2 20,754,759 $280,068,531 -$32,397,507 $13.49 102
2019 Q1 22,072,350 $434,787,882 +$11,621,997 $19.69 99
2018 Q4 21,251,388 $480,634,988 -$22,413,608 $22.62 103
2018 Q3 21,451,260 $796,699,124 +$177,934,928 $37.14 109
2018 Q2 16,555,642 $649,157,809 +$18,398,275 $39.21 102
2018 Q1 16,057,296 $789,001,865 +$27,407,421 $49.14 104
2017 Q4 15,530,216 $702,713,442 +$144,199,771 $45.25 94
2017 Q3 12,365,961 $431,475,805 -$9,177,755 $34.92 71
2017 Q2 12,545,320 $258,622,356 +$12,681,049 $20.65 64
2017 Q1 11,915,179 $301,467,000 +$19,729,891 $25.49 49
2016 Q4 11,664,156 $140,277,170 +$7,379,760 $12.15 36
2016 Q3 11,111,633 $79,350,000 -$991,945 $7.21 35
2016 Q2 11,281,464 $61,873,000 -$5,137,266 $5.55 41
2016 Q1 12,398,866 $61,573,000 -$830,584 $5.02 45
2015 Q4 12,331,269 $92,206,823 -$1,150,846 $7.51 46
2015 Q3 12,381,895 $118,371,122 -$1,738,088 $9.56 50
2015 Q2 12,033,481 $231,762,915 +$26,761,770 $19.26 56
2015 Q1 10,760,000 $142,462,000 +$85,107,616 $13.24 31
2014 Q4 4,299,218 $33,460,000 +$10,974,716 $7.86 22
2014 Q3 1,641,450 $13,445,000 +$13,444,990 $8.19 18